PCDGF Activators
PCDGF Activators encompass a diverse array of chemical compounds that indirectly bolster the functional activity of PCDGF through a variety of signaling pathways. Compounds like Forskolin and IBMX increase intracellular cAMP levels, leading to the activation of PKA, which may phosphorylate substrates involved in the pathways that PCDGF is part of, thus enhancing its activity. Concurrently, PMA, as a PKC activator, and EGCG, a kinase inhibitor, influence multiple signaling cascadesthat can lead to the phosphorylation of proteins associated with PCDGF, resulting in its functional augmentation. LY294002, by inhibiting PI3K, potentially reduces negative feedback loops, thus promoting PCDGF-involved pathways, while Sphingosine-1-phosphate activates G-protein coupled receptors that can trigger downstream signaling enhancing PCDGF activity. Additionally, the tyrosine kinase inhibitor Genistein may activate PCDGF pathways by preventing the inhibitory phosphorylation of key proteins, and U0126, by inhibiting MEK, could reduce ERK-mediated negative feedback, which might otherwise restrain PCDGF-related processes.
The influence of intracellular calcium on PCDGF activity is modulated by compounds such as Thapsigargin and A23187, both of which increase calcium levels within the cell and thus potentiate calcium-dependent kinases that may enhance PCDGF pathways. SB203580's inhibition of p38 MAPK can remove a layer of negative regulation on PCDGF, while Staurosporine, despite its broad-spectrum activity, has the potential to selectively lift inhibitory kinases off PCDGF-associated pathways. These activators, through their targeted effects, offer a biochemical toolkit for indirectly enhancing PCDGF without the need for upregulation at the transcriptional or translational level, instead focusing on the modulation of various signaling pathways and cellular processes that converge on the functional activity of PCDGF.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates PKA (protein kinase A), which can phosphorylate proteins that may be involved in the pathways or biological processes that PCDGF is part of, thereby enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, leading to increased levels of cAMP and cGMP by preventing their degradation. This elevates PKA and PKG activity, which can enhance PCDGF activity by modulating downstream signaling pathways that are positively regulated by PKA/PKG. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a PKC activator which mimics diacylglycerol. Activation of PKC has been shown to influence numerous signaling pathways, potentially enhancing the activity of PCDGF by phosphorylating proteins that interact with or regulate PCDGF. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a kinase inhibitor that can modulate various signaling cascades by inhibiting kinases that negatively regulate pathways involving PCDGF, thus indirectly enhancing PCDGF activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor which can shift cellular signaling dynamics. By inhibiting PI3K, it may reduce negative feedback loops and enhance pathways that are positively regulated by PCDGF. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that can activate signaling pathways involving G-protein coupled receptors, potentially leading to the activation of downstream effectors that enhance PCDGF activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which can lead to the activation of pathways by preventing the phosphorylation of tyrosines on proteins that negatively regulate pathways involving PCDGF, thus indirectly enhancing PCDGF activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor which leads to an increase in intracellular calcium levels. Elevated calcium can activate calcium-dependent kinases, which may enhance the activity of PCDGF by modulating calcium-sensitive pathways it is involved in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor which could lead to the enhancement of PCDGF activity by inhibiting p38 MAPK-mediated negative regulation on pathways involving PCDGF. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, thereby potentially enhancing PCDGF activity by stimulating calcium-dependent signaling pathways that PCDGF is part of. | ||||||